SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $600 | -53.8% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $1,300 | -26.1% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,760 | -43.9% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $3,140 | -37.2% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $4,000 | -33.3% | 1,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $6,000 | -25.0% | 1,000 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $8,000 | -11.1% | 1,000 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $9,000 | -25.0% | 1,000 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $12,000 | -7.7% | 1,000 | 0.0% | 0.01% | -10.0% |
| Q1 2021 | $13,000 | -18.8% | 1,000 | 0.0% | 0.01% | -28.6% |
| Q4 2020 | $16,000 | +77.8% | 1,000 | 0.0% | 0.01% | +75.0% |
| Q3 2020 | $9,000 | 0.0% | 1,000 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $9,000 | +28.6% | 1,000 | -12.5% | 0.01% | +25.0% |
| Q1 2020 | $7,000 | -12.5% | 1,143 | +14.3% | 0.01% | -11.1% |
| Q4 2019 | $8,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |